Since its introduction, mpMRI of the prostate has been changing the management of suspicious PCa, especially in men with non-specific high PSA, where the detection of clinically significant PCa has been shown to be more accurate than standard TRUS biopsy [14]. This evidence concerns the gene KLK3 and posterior cortical atrophy.